Thursday, March 7, 2024

Rakuten Medical Gets $119M In Series E

Rakuten medical, a company developing precision therapies for treating cancer, has raised $119M in a Series E funding round. The company said the new funding came from Hikma, a global pharmaceutical company, and Mizuho Bank and Dai-ichi Life, plus SBI Group, Rakuten Group and its Chairman and CEO, Mickey Mikitani. The company said it will use it to support development of its pipeline. As part of the funding, the company said it has added Mazen Darwazah of Hikma to its board. The company has its U.S. headquarters in San Diego, but is based in Japan.